查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095681

醫療保健第三方物流(3PL) 市場 – 全球市場預測 2026–2032 年

Healthcare Third-party Logistics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療保健第三方物流市場將成長至 4,386 億美元，複合年成長率為 7.39%。

主要市場統計數據
基準年 2025 2661.4億美元
預計年份：2026年 2850.9億美元
預測年份 2032 4386億美元
複合年成長率 (%) 7.39%

醫療保健第三方物流(3PL)執行摘要

醫療保健領域的第三方物流(3PL) 是建構穩健的藥品供應鏈、醫療設備分銷、臨床試驗物流、疫苗物流以及直接病患醫療服務的重要基礎。該領域為溫度敏感型藥品、生物製藥、診斷試劑和高價值醫療技術提供受監管的儲存、運輸、逆向物流、訂單處理、低溫運輸物流和可追溯性支援。生技藥品和細胞/基因療法的成長、日益嚴格的序列化和可追溯性要求、醫療保健採購中不斷成長的電子商務期望以及在複雜的跨境運輸過程中維護產品完整性的需求，共同推動了對專業醫療保健物流的需求。良好分銷規範 (GDP)、良好儲存規範 (GSP)、藥物警戒要求、海關管制和產品安全法規等法規結構，持續規範醫療保健物流供應商應如何管理品質、文件、風險和合規性。在這種環境下，醫療保健 3PL 提供者不再被視為單純的運輸供應商，而是醫療製造商、經銷商、醫院、藥房、實驗室和公共衛生組織的策略合作夥伴，以確保業務連續性、合規性、透明度和以患者為中心的交付績效。

醫療保健第三方物流產業的變革

隨著供應鏈日益以病人為中心，數位監控技術不斷進步，合規措施也日趨嚴格，醫療物流格局正經歷一場結構性變革。低溫運輸物流的範圍已從傳統的冷藏藥品擴展到需要超低溫儲存的生技藥品、專科藥物、臨床試驗樣本以及保存期限極短的個人化療法。同時，疫情期間的供不應求、地緣政治緊張局勢、貨櫃延誤以及供應商集中化等問題，正促使人們重新評估庫存策略，以降低醫療系統中斷的風險。物流網路正從線性履約模式轉向更靈活的區域樞紐、多溫區設施、多元化的承運商網路以及更貼近患者的配送能力。監管力度也不斷加強，監管機構強調文件完整性、溫度偏差控制、產品真偽驗證以及安全的儲存和配送鏈。永續性是另一個關鍵轉變，醫療相關人員要求在不損害病人安全或產品品質的前提下，採用低排放運輸、可重複使用的包裝、最佳化路線和負責任的處置方式。這些趨勢使得擁有檢驗的基礎設施、品管系統、數位可視性和受監管醫療產品專業知識的醫療保健 3PL 合作夥伴的角色變得越來越重要。

人工智慧對醫療保健物流的累積影響

人工智慧 (AI) 透過改善需求預測、路線最佳化、倉庫自動化、溫度監控、異常管理和品質決策，對醫療保健領域的第三方物流產生了日益顯著的影響。在藥品和醫療設備物流方面，AI 驅動的分析有助於識別運輸風險模式、預測延誤、最佳化庫存佈局，並在產品完整性受損之前檢測感測器資料異常。機器學習模式也被用於輔助醫院和藥局進行需求預測、改善履約中心的人員配置計劃，並簡化召回、過期或隔離產品的退貨處理流程。在低溫運輸物流方面，AI 可以透過整合遠端資訊處理、物聯網感測器資料、天氣資料、海關資訊和運輸里程碑來建立預警系統，從而增強控制塔的運作。然而，AI 的實施需要健全的資料管治、檢驗的系統、網路安全措施、人工監督以及符合有關可審計性和文件記錄的監管要求。因此，人工智慧的累積效應不僅限於提高營運效率，還包括增強風險預防、加快介入速度、提供更強力的合規證據以及讓患者更容易獲得必要的醫療產品。

醫療保健第三方物流的關鍵區域洞察

由於製藥製造地的擴張、龐大的患者群體、專科醫療的快速發展，以及主要經濟體和新興市場對低溫運輸基礎設施投資的增加，亞太地區已成為醫療保健第三方物流的重點區域。該地區法規環境的多樣性、島嶼地理特徵、大都會圈交通堵塞以及通往農村地區的長途配送路線，使得跨境合規、溫度控制、海關協調和最後一公里配送的可靠性成為物流績效的核心。歐洲的優點包括：跨多個司法管轄區統一的藥品良好分銷規範 (GDP) 要求、完善的跨境運輸走廊、基於藥品檢驗框架的序列化要求，以及對合規藥品和醫療設備分銷的強勁需求。北美仍然是一個高度發展的醫療保健物流環境，擁有成熟的藥品分銷網路、嚴格的法律規範、廣泛的專科藥房活動，以及對直接患者配送和準時醫療物流的強勁需求。在拉丁美洲，擴大醫療保健服務覆蓋範圍、疫苗分發需求以及藥品進口增加帶來了機遇，但基礎設施差異、複雜的海關程序、貨物安全問題以及溫控運輸要求等問題仍然影響著物流戰略。在非洲，人們越來越關注具有韌性的藥品供應鏈、疫苗低溫運輸能力、捐助者支持的醫療物流以及基本藥物的可近性。同時，分銷的可靠性取決於基礎設施的差異、監管發展以及公共衛生優先事項。在中東，透過對航空貨運、自由區、醫療基礎設施、區域分銷中心以及旨在確保藥品安全的國家醫療轉型計劃的投資，其作為醫療物流門戶的角色正在加強。

各戰略經濟與政策集團的關鍵群體洞察

在北約成員國市場，第三方物流在醫療保健領域的重要性日益凸顯，這體現在危機規劃、藥品儲備、緊急應變物流、安全配送能力以及危機期間關鍵醫療產品持續供應的需求等方面。七國集團（G7）的特點是監管體系先進、藥品供應鏈完善、專科藥品滲透率高，並且越來越重視供應鏈安全、數位化可追溯性、網路韌性和低排放物流。金磚國家（BRICS）憑藉其龐大的人口基數、活躍的藥品生產活動、不斷成長的國內醫療保健消費、不斷擴大的生物製藥能力以及以藥品可及性和供應鏈韌性為重點的政策，對該領域產生了全面影響。歐盟（EU）透過遵守藥物良好分銷規範（GDP）、跨境監管協調、序列化要求、強制性藥物警戒以及藥品運輸和儲存的高品質標準，為醫療保健物流提供了最完善的環境之一。東協地區醫療保健第三方物流的發展受到以下因素的影響：藥品需求的快速成長、群島地區特有的挑戰和跨境配送問題、不斷擴大的醫院網路，以及在大都會圈和偏遠地區對可擴展低溫運輸能力的需求。海灣合作理事會（GCC）成員國正透過投資醫療基礎設施、機場貨運處理能力、區域倉儲、自由區配送以及國家醫療轉型計畫來加強醫療保健物流，這些計畫強調安全及時的藥品配送。

主要國家的發展趨勢正在影響醫療保健物流的需求

中國醫療保健第三方物流 (3PL) 的發展主要受以下因素驅動：藥品消費大規模、生物製藥產能不斷擴張、監管法規日趨現代化、醫院配送日益複雜以及對全國低溫運輸可視性的需求。美國是醫療保健第三方物流的重要市場，這得益於其複雜的藥品分銷管道、對特種藥品的強勁需求、對溫控物流的需求、嚴格的產品可追溯性要求以及對嚴苛品質系統的期望。日本成熟的醫療保健體係要求服務可靠性高、品管嚴格、適應老齡化社會，並需要針對先進療法、診斷和醫療設備的專業物流。印度不僅是重要的藥品製造地，其國內醫療保健需求也不斷成長，因此品管的倉儲、出口物流、低溫運輸完整性和溫控配送的重要性日益凸顯。德國憑藉先進的藥品生產、高品質的倉儲管理標準、符合良好分銷規範 (GDP) 的配送以及高效的多模態基礎設施，繼續在歐洲醫療保健物流領域發揮核心作用。英國的醫療保健物流格局反映了其強大的藥物研發活動、國家醫療保健採購需求、臨床試驗能力以及脫歐後的海關和監管考慮。澳洲需要在幅員遼闊的國土上建立具有韌性的醫療保健物流，並滿足嚴格的藥品要求、生物安全管理以及在都市區和偏遠地區都需建立可靠的低溫運輸。法國將嚴格的醫療保健法規與藥品生產、醫院配送需求以及對受監管的溫控物流日益成長的需求相結合。韓國透過先進的生物製藥生產、數位基礎設施、出口導向生命科學活動以及高標準的受監管物流來強化其醫療保健物流。義大利和西班牙是歐洲重要的藥品和醫療設備物流市場，這得益於其製造能力、醫院網路以及對符合GDP標準的配送的需求。加拿大醫療保健物流的重點在於在廣闊的地理區域內實現可靠的全國性配送、低溫運輸性能、公共衛生物資供應的連續性以及雙語監管文件要求。俄羅斯的醫療保健物流環境受到其地理範圍、進口法規、國內藥品供應優先事項以及對可靠的長途低溫運輸網路的需求的影響。巴西大規模的醫療保健系統和區域差異意味著，醫療物流依賴健全的分銷網路、低溫運輸能力、安全運輸以及對國家衛生監測要求的遵守。墨西哥在醫療產品製造和近岸外包相關的物流正變得日益重要，跨境貿易、海關合規、溫度控制和安全運輸正在影響著企業的商業策略。

為醫療保健行業的第三方物流領導者提供的實用建議

產業領導者應優先考慮檢驗的低溫運輸基礎設施、即時貨物可視性和品管體系，以支援所有運輸和倉儲營運環節的監管審計。在物流網路中引入區域冗餘可以降低因海關延誤、極端天氣、地緣政治事件、港口擁塞、勞動力短缺或單節點故障造成的損失。醫療保健第三方物流供應商應投資於控制塔功能、物聯網監控、人工智慧驅動的風險分析和標準化異常管理協議，以保護產品完整性並加速糾正措施的實施。與製藥公司、醫療設備製造商、醫院、藥房、實驗室和公共衛生組織的夥伴關係不應僅基於成本，而應基於可衡量的服務品質、合規文件、數據透明度和病患治療效果。永續發展措施應著重於路線最佳化、節能設施、可重複使用且檢驗的包裝以及負責任的廢棄物管理，同時確保溫度控制和安全要求不受影響。此外，領導者需要加強網路安全、員工培訓、海關專業知識、供應商合格、運輸路線檢驗和業務永續營運計劃，以應對全球醫療保健供應鏈日益成長的複雜性。

調查方法

本執行摘要採用系統性的二手研究途徑編寫，重點關注檢驗的公共領域和行業認可的資訊來源。此調查方法強調監管指南、政府衛生和海關出版刊物、世界衛生組織 (WHO) 資料、藥品分銷標準、貿易單據、物流基礎設施指標以及經同行評審或技術檢驗的供應鏈文獻。研究結果經過定性整合，旨在識別醫療物流第三方物流 (3PL) 的營運趨勢、區域趨勢、監管影響、技術採用模式和策略重點。本分析不涉及市場規模估算、市場佔有率評估或預測；而是專注於基於證據的主題，例如低溫運輸韌性、良好分銷規範 (GDP) 的合規性、人工智慧 (AI) 的應用、可追溯性、風險管理和以患者為中心的配送。透過比較多個資訊來源類別（包括法律規範、醫療保健系統優先事項、物流能力指標和已記錄的供應鏈挑戰），採用交叉檢驗，以確保結論反映可觀察到的行業實際情況，而非推測性估計。

結論

醫療保健領域的第三方物流正在演變為一項專業化、技術驅動、合規主導的職能，成為全球藥品可近性的核心。生技藥品、疫苗和專科藥物的興起，臨床試驗的去中心化，醫療設備日益複雜化以及直接送藥給患者的趨勢，都推動了對檢驗存儲、精準運輸、端到端可視性和完善文檔的需求。區域、集團和國家層面的趨勢表明，醫療保健物流策略必須根據基礎設施成熟度、監管要求、當地情況、海關程序、安全風險和公共衛生優先事項進行客製化。人工智慧、物聯網驅動的監控、控制塔營運和彈性網路設計正成為提高服務可靠性和保障產品品質的關鍵工具。那些能夠將監管合規性、數位化透明度、卓越的低溫運輸管理和協作規劃相結合的組織，將更有能力在日益複雜的全球供應鏈中，安全、可靠、及時地交付醫療保健產品。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 醫療保健領域的第三方物流(3PL) 市場：依類型分類

  • 低溫運輸物流
  • 非低溫運輸/常溫物流
  • 溫控物流
  • 專業和關鍵物流

第8章 醫療保健領域的第三方物流(3PL) 市場：依服務類型分類

  • 運輸
  • 倉庫/存儲
  • 低溫運輸管理
  • 庫存管理
  • 分配

第9章 醫療保健領域的第三方物流(3PL) 市場：依醫療產業分類

  • 生物製劑
  • 醫療器材
  • 製藥
    • 品牌藥品
    • 學名藥
  • 疫苗

第10章 醫療保健第三方物流（3PL）市場：以劑型分類

  • 固態的
  • 液體
  • 半固態

第11章 醫療保健產業的第三方物流(3PL) 市場：以運輸方式分類

  • 航空
  • 鐵路
  • 道路運輸
    • 整車裝載
    • 小貨物運輸
  • 海上運輸

第12章 醫療保健領域的第三方物流(3PL) 市場：依最終用戶分類

  • 製藥公司
  • 生物製藥公司
  • 藥局
  • 醫療設備製造商
  • 醫院和診所

第13章 醫療保健產業第三方物流(3PL) 市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章 醫療保健第三方物流(3PL) 市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章 醫療保健領域的第三方物流(3PL) 市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aeronet Worldwide
  • CH Robinson Worldwide, Inc.
  • Cardinal Health, Inc.
  • Cencora, Inc.
  • CEVA Logistics AG
  • Cleo Communications
  • CNA Freight LLC
  • Dachser Group SE & Co. KG
  • DCL Logistics
  • Deutsche Post AG
  • DSV A/S
  • Expeditors International of Washington, Inc.
  • Extensiv
  • FedEx Corporation
  • Fulfillment Plus, Inc.
  • Geodis SA
  • Jam-n Logistics
  • Kerry Logistics Network Limited
  • Kuehne+Nagel International AG
  • Labgistics
  • Nippon Express Holdings, Inc.
  • Razr Logistics LLC
  • SEKO Logistics
  • Sinotrans Group
  • United Parcel Service of America, Inc.
  • XPO, Inc.
  • Yusen Logistics Co., Ltd.
Product Code: MRR-F927BA461D86

The Healthcare Third-party Logistics Market is projected to grow by USD 438.60 billion at a CAGR of 7.39% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 266.14 billion
Estimated Year [2026] USD 285.09 billion
Forecast Year [2032] USD 438.60 billion
CAGR (%) 7.39%

Healthcare Third-party Logistics Executive Summary

Healthcare third-party logistics (3PL) has become a mission-critical enabler of resilient pharmaceutical supply chains, medical device distribution, clinical trial logistics, vaccine logistics, and direct-to-patient healthcare delivery. The sector supports regulated storage, transportation, reverse logistics, order fulfillment, cold chain logistics, and traceability for temperature-sensitive medicines, biologics, diagnostics, and high-value medical technologies. Demand for specialized healthcare logistics is being shaped by the growth of biologics and cell and gene therapies, stricter serialization and traceability requirements, rising e-commerce-like expectations in healthcare procurement, and the need to maintain product integrity across complex cross-border routes. Regulatory frameworks such as Good Distribution Practice, Good Storage Practice, pharmacovigilance requirements, customs controls, and product security rules continue to define how healthcare logistics providers manage quality, documentation, risk, and compliance. In this environment, healthcare 3PL providers are no longer viewed only as transportation vendors; they are strategic partners that help healthcare manufacturers, distributors, hospitals, pharmacies, laboratories, and public health agencies achieve continuity, compliance, visibility, and patient-centric delivery performance.

Transformative Shifts in the Healthcare 3PL Landscape

The healthcare logistics landscape is undergoing structural transformation as supply chains become more patient-centric, digitally monitored, and compliance-intensive. Cold chain distribution is expanding beyond traditional refrigerated pharmaceuticals to include ultra-low-temperature biologics, specialty medicines, clinical trial samples, and personalized therapies with narrow handling windows. At the same time, healthcare systems are redesigning inventory strategies to reduce disruption risk following pandemic-era shortages, geopolitical tension, container delays, and supplier concentration concerns. Logistics networks are shifting from linear, centralized models toward more flexible regional hubs, multi-temperature facilities, diversified carrier networks, and near-patient fulfillment capabilities. Regulatory scrutiny is also intensifying, with authorities emphasizing documentation integrity, temperature excursion management, product authentication, and secure chain of custody. Sustainability is another important shift, as healthcare stakeholders seek lower-emission transport, reusable packaging, optimized routing, and responsible disposal without compromising patient safety or product quality. These forces are elevating the role of healthcare 3PL partners with validated infrastructure, quality management systems, digital visibility, and specialized expertise in regulated medical products.

Cumulative Impact of Artificial Intelligence on Healthcare Logistics

Artificial intelligence is increasingly influencing healthcare third-party logistics by improving forecasting, route optimization, warehouse automation, temperature monitoring, exception management, and quality decision-making. In pharmaceutical and medical device logistics, AI-enabled analytics can help identify shipment risk patterns, predict delays, optimize inventory placement, and detect anomalies in sensor data before product integrity is compromised. Machine learning models are also being used to support demand sensing for hospitals and pharmacies, improve labor planning in fulfillment centers, and enhance returns processing for recalled, expired, or quarantined products. For cold chain logistics, AI can strengthen control tower operations by combining telematics, Internet of Things sensor feeds, weather data, customs information, and transportation milestones into early-warning systems. However, adoption requires strong data governance, validated systems, cybersecurity controls, human oversight, and alignment with regulatory expectations for auditability and documentation. The cumulative impact of artificial intelligence is therefore not only operational efficiency, but also better risk prevention, faster intervention, improved compliance evidence, and more reliable patient access to critical healthcare products.

Key Regional Insights for Healthcare Third-party Logistics

Asia-Pacific is a high-priority region for healthcare third-party logistics due to its expanding pharmaceutical manufacturing base, large patient populations, rapid growth in specialty care, and increasing investments in cold chain infrastructure across major economies and emerging markets. The region's diverse regulatory environments, island geographies, megacity congestion, and long rural delivery routes make cross-border compliance, temperature control, customs coordination, and last-mile reliability central to logistics performance. Europe benefits from harmonized Good Distribution Practice expectations across many jurisdictions, sophisticated cross-border transport corridors, serialization requirements under the medicines verification framework, and strong demand for compliant pharmaceutical and medical device distribution. North America remains a highly advanced healthcare logistics environment supported by mature pharmaceutical distribution networks, strict regulatory oversight, extensive specialty pharmacy activity, and strong demand for direct-to-patient and time-critical medical logistics. Latin America presents opportunities driven by healthcare access expansion, vaccine distribution needs, and growing pharmaceutical imports, while infrastructure gaps, customs complexity, cargo security concerns, and temperature-sensitive transport requirements continue to influence logistics strategies. Africa is increasingly focused on resilient medicine supply chains, vaccine cold chain capacity, donor-supported healthcare logistics, and improved access to essential medicines, with distribution reliability shaped by infrastructure variability, regulatory development, and public health priorities. The Middle East is strengthening its role as a healthcare logistics gateway through investments in air cargo, free zones, healthcare infrastructure, regional distribution hubs, and national healthcare transformation programs focused on secure medicine availability.

Key Group Insights Across Strategic Economic and Policy Blocs

NATO member markets add relevance to healthcare third-party logistics through preparedness planning, medical stockpiling, emergency response logistics, secure distribution capabilities, and continuity requirements for critical health products during crises. G7 countries are characterized by advanced regulatory systems, established pharmaceutical supply chains, high specialty medicine adoption, and growing emphasis on supply chain security, digital traceability, cyber resilience, and lower-emission logistics. BRICS economies collectively influence the sector through large populations, significant pharmaceutical manufacturing activity, rising domestic healthcare consumption, expanding biologics capabilities, and policy focus on medicine access and supply chain resilience. The European Union provides one of the most structured environments for healthcare logistics due to Good Distribution Practice alignment, cross-border regulatory coordination, serialization requirements, pharmacovigilance obligations, and strong quality expectations for pharmaceutical transport and storage. ASEAN healthcare third-party logistics is shaped by fast-growing pharmaceutical demand, archipelagic and cross-border distribution challenges, expanding hospital networks, and the need for scalable cold chain capabilities across both metropolitan and remote areas. The GCC is strengthening healthcare logistics through investments in medical infrastructure, airport cargo capacity, regional warehousing, free-zone distribution, and national healthcare transformation programs that emphasize secure and timely medicine distribution.

Key Country Insights Shaping Healthcare Logistics Demand

China's healthcare 3PL development is driven by large-scale pharmaceutical consumption, expanding biologics capacity, regulatory modernization, hospital distribution complexity, and demand for nationwide cold chain visibility. The United States is a leading healthcare 3PL environment supported by complex pharmaceutical distribution channels, strong specialty drug demand, temperature-controlled logistics needs, strict product traceability requirements, and rigorous quality system expectations. Japan's mature healthcare system requires high service reliability, strict quality handling, aging-population support, and specialized logistics for advanced therapies, diagnostics, and medical devices. India combines a major pharmaceutical manufacturing base with growing domestic healthcare demand, making quality-controlled storage, export logistics, cold chain integrity, and temperature-managed distribution increasingly important. Germany remains central to European healthcare logistics through advanced pharmaceutical manufacturing, high-quality warehousing standards, GDP-compliant distribution, and efficient multimodal transport infrastructure. The United Kingdom's healthcare logistics landscape reflects strong pharmaceutical research activity, national healthcare procurement needs, clinical trial capability, and post-Brexit customs and regulatory considerations. Australia depends on resilient healthcare logistics across long domestic distances, strict therapeutic goods requirements, biosecurity controls, and cold chain reliability for both urban and remote communities. France combines strong healthcare regulation, pharmaceutical production, hospital distribution needs, and growing demand for compliant temperature-controlled logistics. South Korea is strengthening healthcare logistics through advanced biopharmaceutical production, digital infrastructure, export-oriented life sciences activity, and high standards for regulated distribution. Italy and Spain are important European pharmaceutical and medical device logistics markets, supported by manufacturing capabilities, hospital networks, and demand for GDP-compliant distribution. Canada's healthcare logistics priorities center on reliable national distribution across vast geographies, cold chain performance, public health supply continuity, and bilingual regulatory documentation requirements. Russia's healthcare logistics environment is shaped by geographic scale, import controls, domestic medicine supply priorities, and the need for reliable cold chain coverage across long distances. Brazil's large healthcare system and regional disparities make medical logistics dependent on robust distribution networks, cold chain capacity, secure transport, and compliance with national health surveillance requirements. Mexico is increasingly important for healthcare manufacturing and nearshoring-related logistics, with cross-border trade, customs compliance, temperature control, and secure transport shaping operational strategies.

Actionable Recommendations for Healthcare 3PL Leaders

Industry leaders should prioritize validated cold chain infrastructure, real-time shipment visibility, and quality management systems that support regulatory audit readiness across all transportation and warehousing activities. Building regional redundancy into logistics networks can reduce exposure to disruptions caused by customs delays, extreme weather, geopolitical events, port congestion, labor constraints, or single-node failures. Healthcare 3PL providers should invest in control tower capabilities, Internet of Things monitoring, AI-enabled risk analytics, and standardized exception management protocols to protect product integrity and accelerate corrective action. Partnerships with pharmaceutical manufacturers, medical device producers, hospitals, pharmacies, laboratories, and public health agencies should be structured around measurable service quality, compliance documentation, data transparency, and patient outcomes rather than cost alone. Sustainability initiatives should focus on route optimization, energy-efficient facilities, reusable validated packaging, and responsible waste handling while ensuring that temperature and safety requirements remain uncompromised. Leaders should also strengthen cybersecurity, workforce training, customs expertise, supplier qualification, lane validation, and business continuity planning to meet the rising complexity of global healthcare supply chains.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified public-domain and industry-recognized sources. The methodology emphasizes regulatory guidance, government health and customs publications, international health agency materials, pharmaceutical distribution standards, trade documentation, logistics infrastructure indicators, and peer-reviewed or technically validated supply chain literature. Insights are synthesized qualitatively to identify operational trends, regional dynamics, regulatory implications, technology adoption patterns, and strategic priorities in healthcare third-party logistics. The analysis avoids market sizing, market share evaluation, and forecasting, and instead focuses on evidence-backed themes such as cold chain resilience, Good Distribution Practice compliance, artificial intelligence adoption, traceability, risk management, and patient-centric distribution. Cross-validation is applied by comparing multiple source categories, including regulatory frameworks, health system priorities, logistics capability indicators, and documented supply chain challenges, to ensure that conclusions reflect observable industry realities rather than speculative estimates.

Conclusion

Healthcare third-party logistics is evolving into a specialized, technology-enabled, and compliance-driven function at the center of global healthcare access. The rise of biologics, vaccines, specialty medicines, clinical trial decentralization, medical device complexity, and direct-to-patient delivery is increasing the need for validated storage, precise transportation, end-to-end visibility, and robust documentation. Regional, group, and country-level dynamics show that healthcare logistics strategies must be tailored to infrastructure maturity, regulatory requirements, geography, customs processes, security risks, and public health priorities. Artificial intelligence, IoT-enabled monitoring, control tower operations, and resilient network design are becoming essential tools for improving service reliability and protecting product quality. Organizations that combine regulatory discipline, digital transparency, cold chain excellence, and collaborative planning will be best positioned to support safe, secure, and timely delivery of healthcare products in an increasingly complex global supply chain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Healthcare Third-party Logistics Market, by Type

  • 7.1. Introduction
  • 7.2. Cold Chain Logistics
  • 7.3. Non-Cold Chain / Ambient Logistics
  • 7.4. Controlled Room Temperature Logistics
  • 7.5. Specialty / Critical Logistics

8. Healthcare Third-party Logistics Market, by Service Type

  • 8.1. Introduction
  • 8.2. Transportation
  • 8.3. Warehousing & Storage
  • 8.4. Cold Chain Management
  • 8.5. Inventory Management
  • 8.6. Distribution

9. Healthcare Third-party Logistics Market, by Healthcare Type

  • 9.1. Introduction
  • 9.2. Biologics
  • 9.3. Medical Devices
  • 9.4. Pharmaceuticals
    • 9.4.1. Branded Drugs
    • 9.4.2. Generic Drugs
  • 9.5. Vaccines

10. Healthcare Third-party Logistics Market, by Dosage Form

  • 10.1. Introduction
  • 10.2. Solid Dosage Forms
  • 10.3. Liquid Dosage Forms
  • 10.4. Semi-Solid Dosage Forms

11. Healthcare Third-party Logistics Market, by Transportation Mode

  • 11.1. Introduction
  • 11.2. Air
  • 11.3. Rail
  • 11.4. Road
    • 11.4.1. Full Truckload
    • 11.4.2. Less-Than-Truckload
  • 11.5. Sea

12. Healthcare Third-party Logistics Market, by End User

  • 12.1. Introduction
  • 12.2. Pharmaceutical Companies
  • 12.3. Biopharmaceutical Companies
  • 12.4. Pharmacies
  • 12.5. Medical Device Manufacturers
  • 12.6. Hospitals & Clinics

13. Healthcare Third-party Logistics Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Healthcare Third-party Logistics Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Healthcare Third-party Logistics Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aeronet Worldwide
  • 17.2. C.H. Robinson Worldwide, Inc.
  • 17.3. Cardinal Health, Inc.
  • 17.4. Cencora, Inc.
  • 17.5. CEVA Logistics AG
  • 17.6. Cleo Communications
  • 17.7. CNA Freight LLC
  • 17.8. Dachser Group SE & Co. KG
  • 17.9. DCL Logistics
  • 17.10. Deutsche Post AG
  • 17.11. DSV A/S
  • 17.12. Expeditors International of Washington, Inc.
  • 17.13. Extensiv
  • 17.14. FedEx Corporation
  • 17.15. Fulfillment Plus, Inc.
  • 17.16. Geodis SA
  • 17.17. Jam-n Logistics
  • 17.18. Kerry Logistics Network Limited
  • 17.19. Kuehne + Nagel International AG
  • 17.20. Labgistics
  • 17.21. Nippon Express Holdings, Inc.
  • 17.22. Razr Logistics LLC
  • 17.23. SEKO Logistics
  • 17.24. Sinotrans Group
  • 17.25. United Parcel Service of America, Inc.
  • 17.26. XPO, Inc.
  • 17.27. Yusen Logistics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLD CHAIN LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLD CHAIN LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLD CHAIN LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-COLD CHAIN / AMBIENT LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-COLD CHAIN / AMBIENT LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-COLD CHAIN / AMBIENT LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONTROLLED ROOM TEMPERATURE LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTROLLED ROOM TEMPERATURE LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONTROLLED ROOM TEMPERATURE LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY / CRITICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY / CRITICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY / CRITICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRANSPORTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TRANSPORTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRANSPORTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WAREHOUSING & STORAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WAREHOUSING & STORAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WAREHOUSING & STORAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLD CHAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLD CHAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLD CHAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INVENTORY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INVENTORY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INVENTORY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISTRIBUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISTRIBUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRANDED DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRANDED DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRANDED DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GENERIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SOLID DOSAGE FORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SOLID DOSAGE FORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SOLID DOSAGE FORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIQUID DOSAGE FORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIQUID DOSAGE FORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIQUID DOSAGE FORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SEMI-SOLID DOSAGE FORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEMI-SOLID DOSAGE FORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SEMI-SOLID DOSAGE FORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ROAD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROAD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ROAD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FULL TRUCKLOAD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FULL TRUCKLOAD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FULL TRUCKLOAD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LESS-THAN-TRUCKLOAD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LESS-THAN-TRUCKLOAD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LESS-THAN-TRUCKLOAD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 157. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 158. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 159. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 160. NATO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 166. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 167. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 168. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 169. G7 HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 203. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 205. GCC HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 239. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 240. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 241. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 242. INDIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 266. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 267. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 268. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 269. AUSTRALIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 275. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 284. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 285. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 286. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 287. SOUTH KOREA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 293. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 294. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 295. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 296. ITALY HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 320. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY HEALTHCARE TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 329. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 330. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 331. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY ROAD, 2018-2032 (USD MILLION)
  • TABLE 332. MEXICO HEALTHCARE THIRD-PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN HEALTHCARE THIRD-P